The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. [electronic resource]
Producer: 20020212Description: 1338-47 p. digitalISSN:- 0022-1767
- Amino Acid Substitution -- genetics
- Antigen Presentation -- genetics
- Carcinoma, Squamous Cell -- genetics
- Cells, Cultured
- Cytotoxicity Tests, Immunologic
- Epitopes, T-Lymphocyte -- genetics
- Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
- HLA-A2 Antigen -- metabolism
- Humans
- Immune Tolerance -- genetics
- Leukocytes, Mononuclear -- immunology
- Lymphocyte Activation -- genetics
- Mouth Neoplasms -- genetics
- Peptide Fragments -- genetics
- Protein Binding -- genetics
- Receptors, Antigen, T-Cell, alpha-beta -- biosynthesis
- T-Lymphocyte Subsets -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.